Mass screening for colorectal cancer by testing fecal occult blood
- 1 June 1986
- Vol. 57 (11) , 2241-2245
- https://doi.org/10.1002/1097-0142(19860601)57:11<2241::aid-cncr2820571129>3.0.co;2-t
Abstract
The validity of screening for colorectal cancer by testing for occult blood on 2 successive days was evaluated over a 2-year period beginning April 1980 by testing 9449 individuals without symptoms. The Shionogi slide (Shionogi Pharmaceutical Co., Osaka, Japan), a commercial guaiac-impregnated slide with moderate sensitivity, was used for screening subjects under dietary restriction. Of the 1401 persons (14.8%) who had a positive reaction for occult blood, 858 (61.2%) received further diagnostic examinations, and 265 of them proved to have one or more abnormalities of the gastrointestinal tract. Colorectal cancer was detected in 11 persons and polyps in 91 persons. Eight of the cancers were in an early stage. This screening method was found to be suitable for large-scale mass screening, and appears to have high diagnostic value.This publication has 11 references indexed in Scilit:
- MASS SCREENING IN COLORECTAL CANCERAnz Journal of Surgery, 1980
- A mass screening program for colorectal cancer using chemical testing for occult blood in the stoolCancer, 1980
- Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasiaCancer, 1980
- SCREENING FOR SYMPTOMLESS COLORECTAL CANCER BY TESTING FOR OCCULT BLOOD IN GENERAL PRACTICEThe Lancet, 1980
- OCCULT BLOOD TESTSThe Lancet, 1980
- Screening for colorectal cancer: An overviewCancer, 1980
- OCCULT BLOOD TESTS AND COLORECTAL TUMOURSThe Lancet, 1980
- Comparative educational approaches to screening for colorectal cancer.American Journal of Public Health, 1978
- Mass screening for colorectal cancerThe American Journal of Surgery, 1974
- Occult blood testing for detection of asymptomatic colon cancerCancer, 1971